Although 'recreational' regulation of marijuana remains a hot topic, Canada already currently has one of the most comprehensive, federally legal medical marijuana regulatory systems in the world under Health Canada's Marijuana for Medical Purposes Regulations (MMPR). Licensed Producers – the only legal, commercial producers of marijuana in Canada – must adhere to quality assurance standards similar to those in place for commercial pharmaceuticals.
Within the industry, there is an ongoing debate about these quality assurance practices and how they relate to production, sale, and public health. To engage community members in this dialogue, Lift Cannabis Co. will be holding a forum on May 7th at UBC Robson Square at 6:00pm.
The panelists represent all facets of the industry, from Brent Zettl, President and CEO of CanniMed (the oldest legal, commercial licensed producer in Canada), to Dieter McPherson, Executive Director of the Victoria Cannabis Buyers Club (one of the oldest medical marijuana dispensaries in Canada). UBC adjunct professors Jonathan Page (Botany Department) and Mark Haden (School of Population and Public Health) round out the panel and will examine testing methodology and the effects of regulation on public health from a harm reduction standpoint.
Topics for discussion at the forum include: adhering to existing pharmacopoeia, passing Health Canada inspections, when and where irradiation is important for those with compromised immune systems, and costs of implementing these regulations.
The forum also features three special presenters:
-Philippe Lucas, VP of Patient Research & Services at Tilray and PhD student in the University of Victoria's Social Dimensions of Health program
-Emily Kirkham, VP of Laboratory Operations at Signoto, a leading provider of quality control consulting to the Canadian medical cannabis industry
-Jonathan Zaid, a 22-year-old Ontario student who was one of the first Canadians to successfully argue for and obtain private health care coverage of his medical marijuana costs, and by doing so, set a legal precedent for the country
Hilary Black, the founder of the first medical cannabis dispensary in Canada, will moderate the forum.
Within the industry, there is an ongoing debate about these quality assurance practices and how they relate to production, sale, and public health. To engage community members in this dialogue, Lift Cannabis Co. will be holding a forum on May 7th at UBC Robson Square at 6:00pm.
The panelists represent all facets of the industry, from Brent Zettl, President and CEO of CanniMed (the oldest legal, commercial licensed producer in Canada), to Dieter McPherson, Executive Director of the Victoria Cannabis Buyers Club (one of the oldest medical marijuana dispensaries in Canada). UBC adjunct professors Jonathan Page (Botany Department) and Mark Haden (School of Population and Public Health) round out the panel and will examine testing methodology and the effects of regulation on public health from a harm reduction standpoint.
Topics for discussion at the forum include: adhering to existing pharmacopoeia, passing Health Canada inspections, when and where irradiation is important for those with compromised immune systems, and costs of implementing these regulations.
The forum also features three special presenters:
-Philippe Lucas, VP of Patient Research & Services at Tilray and PhD student in the University of Victoria's Social Dimensions of Health program
-Emily Kirkham, VP of Laboratory Operations at Signoto, a leading provider of quality control consulting to the Canadian medical cannabis industry
-Jonathan Zaid, a 22-year-old Ontario student who was one of the first Canadians to successfully argue for and obtain private health care coverage of his medical marijuana costs, and by doing so, set a legal precedent for the country
Hilary Black, the founder of the first medical cannabis dispensary in Canada, will moderate the forum.
--
David BrownCommunications Director | Lift
David BrownCommunications Director | Lift
This e-mail (including any attachments) is confidential and may be legally privileged. If you are not an intended recipient or an authorized representative of an intended recipient, you are prohibited from using, copying or distributing the information in this e-mail or its attachments.
If you have received this e-mail in error, please notify the sender immediately by return e-mail and delete all copies of this message and any attachments.
0 comments:
Post a Comment